Kratzel, A.* ; Kelly, J.N.* ; V'kovski, P.* ; Portmann, J.* ; Brüggemann, Y.* ; Todt, D.* ; Ebert, N.* ; Shrestha, N.* ; Plattet, P.* ; Staab-Weijnitz, C.A. ; von Brunn, A. * ; Steinmann, E.* ; Dijkman, R.* ; Zimmer, G.* ; Pfaender, S.* ; Thiel, V.*
A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.
PLoS Biol. 19:e3001490 (2021)
Over the past 20 years, 3 highly pathogenic human coronaviruses (HCoVs) have emerged-Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and, most recently, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-demonstrating that coronaviruses (CoVs) pose a serious threat to human health and highlighting the importance of developing effective therapies against them. Similar to other viruses, CoVs are dependent on host factors for their survival and replication. We hypothesized that evolutionarily distinct CoVs may exploit similar host factors and pathways to support their replication cycles. Herein, we conducted 2 independent genome-wide CRISPR/Cas-9 knockout (KO) screens to identify MERS-CoV and HCoV-229E host dependency factors (HDFs) required for HCoV replication in the human Huh7 cell line. Top scoring genes were further validated and assessed in the context of MERS-CoV and HCoV-229E infection as well as SARS-CoV and SARS-CoV-2 infection. Strikingly, we found that several autophagy-related genes, including TMEM41B, MINAR1, and the immunophilin FKBP8, were common host factors required for pan-CoV replication. Importantly, inhibition of the immunophilin protein family with the compounds cyclosporine A, and the nonimmunosuppressive derivative alisporivir, resulted in dose-dependent inhibition of CoV replication in primary human nasal epithelial cell cultures, which recapitulate the natural site of virus replication. Overall, we identified host factors that are crucial for CoV replication and demonstrated that these factors constitute potential targets for therapeutic intervention by clinically approved drugs.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Respiratory Syndrome Coronavirus; Cyclosporine-a; Functional Receptor; Cyclophilin-a; Replication; Virus; Calcineurin; Complex; Gene; Ace2
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
1544-9173
e-ISSN
1545-7885
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 19,
Heft: 12,
Seiten: ,
Artikelnummer: e3001490
Supplement: ,
Reihe
Verlag
Public Library of Science (PLoS)
Verlagsort
1160 Battery Street, Ste 100, San Francisco, Ca 94111 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
80000 - German Center for Lung Research
Forschungsfeld(er)
Lung Research
PSP-Element(e)
G-501800-817
Förderungen
Federal Ministry of Education and Research (RAPID grant)
Horizon 2020 Marie Sklodowska-Curie "COV RESTRICT"
Swiss National Science Foundation
Copyright
Erfassungsdatum
2022-01-19